Forte (FBRX) Posts Dismal Data on Atopic Dermatitis Candidate
Forte’s (FBRX) mid-stage study on its lead candidate FB-401 to address the condition of atopic dermatitis fails to meet its primary…
Zacks.com
3 Stocks to Watch as the Football Mania Grips Americans
Companies with exposure to sports betting business may emerge as good investment options to hold onto as football season kicks…
Euronet (EEFT) Arm Integrates PayPal QR Code to Aid Retailers
Euronet’s (EEFT) epay unit enhances its portfolio by providing the PayPal QR Code for the brick-and-mortar retailers.
Marsh & McLennan (MMC) Subsidiary Buys Vaaler Insurance
Marsh & McLennan (MMC) arm acquires North Dakota-based Vaaler Insurance to enhance its portfolio.
Is Buckle (BKE) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find…
PetroChina’s (PTR) Blowout H1 Earnings Signal Turnaround
PetroChina (PTR) aims to shift a third of its capital to low-carbon energy projects by 2035, highlighting its green push.
Can Earnings Continue to Improve?
We know that the earnings picture remains strong, even though the growth pace is expected to decelerate significantly in Q3 and…
NXP Semiconductors (NXPI) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, NXP Semiconductors (NXPI) closed at $211.50, marking a -1.69% move from the previous day.
Raytheon Technologies (RTX) Stock Sinks As Market Gains: What You Should Know
Raytheon Technologies (RTX) closed at $84.10 in the latest trading session, marking a -0.78% move from the prior day.